B/F/TAF vs Atripla Double-Blind Switch Study in HIV-1 Infected Adults

NCT03532425 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

28

Enrollment

OTHER

Sponsor class

Stopped Difficulties enrolling participants

Conditions

HIV-1-infection

Interventions

DRUG: B/F/TAF
DRUG: Atripla
DRUG: B/F/TAF Placebo
DRUG: Atripla Placebo

Sponsor

University of Alberta

Collaborators

[object Object]
[object Object]